Seeking viable strategies to advance patient care, enable innovation, and sustain their businesses, life sciences companies, hospitals, and health systems are breaking from siloed traditions to join forces. Through these strategic partnerships, they pool resources, share risk, and reinforce the value propositions for new therapies.
The main drivers of these partnerships are economics, technological advances, and population-scale management.
Access to an unprecedented amount of data and the ability to analyze it also brings companies together to determine how to use that data to inform and improve patient care. Navigant, a Guidehouse company, recently hosted a panel discussion on best practices for creating successful partnerships, featuring the following life sciences and provider leaders:
Anand Chokkalingam, senior director of Clinical Research, Gilead Sciences
Joseph Grzymski, chief scientific officer, Renown Health
James Lu, MD, PhD, co-founder and chief scientific officer, Applied Genomics, Helix
Anthony Slonim, MD, DrPH, president and CEO, Renown Health